PT - JOURNAL ARTICLE AU - Ezeh, Ebubechukwu AU - Perdoncin, Maddie AU - Ogbu, Chukwuemeka AU - Akhigbe, Esiemoghie AU - Al-Hiari, Mohammed AU - Ramalingam, Archana AU - Saunders, Elizabeth AU - Mader, Jason AU - Rodriguez Lozano, Patricia F. TI - Cardiovascular Risks Among the Transgender Population in Rural United States: Spotlight on the Appalachian Region AID - 10.1101/2023.09.13.23295518 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.13.23295518 4099 - http://medrxiv.org/content/early/2023/09/14/2023.09.13.23295518.short 4100 - http://medrxiv.org/content/early/2023/09/14/2023.09.13.23295518.full AB - Background Gender diverse populations have disproportionately worse cardiovascular (CV) outcomes. However, the data on the prevalence of cardiovascular risk factors among the transgender population in rural Appalachia remains limited. The purpose of this study was to determine the prevalence of CV risk factors among the transgender population in rural Appalachia.Methods This retrospective case-control study from an Appalachian university teaching hospital clinic matched transgender individuals with controls from the same clinic. Logistic regression model was performed to determine the prevalence of CV risk factors among the transgender population in comparison to their cisgender counterparts.Results The total number of transgender and cisgender individuals identified were 89 and 69, respectively. After adjusting for age and family history of atherosclerotic CV disease, transgender status remained independently associated with tobacco use (adjusted odds ratio [aOR] 6.64 [2.59-17.01]) and prediabetes/diabetes mellitus (aOR 3.98 [1.05-15.15]). Among the transgender population, there were increased odds of obesity (aOR 13.39 [3.30-54.30] and hyperlipidemia (aOR 3.46 [1.03-11.59]) in the transgender male group compared to the transgender female group. In another subgroup analysis, transgender individuals who underwent surgical and/or hormonal treatment had significantly higher odds of tobacco use (aOR 6.67 [2.80-15.98]), statin need (aOR 3.97 [1.14-13.81], and alcohol use (aOR 11.31 [1.34-95.53]). Increased statin use tends to be associated with normal LDL levels.Conclusions In rural Appalachia, transgender status is associated with disproportionately higher odds of tobacco use, elevated blood glucose and other CV risk factors.Competing Interest StatementDr. Rodriguez is an iTHRIV Scholar. The iTHRIV Scholars Program is supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers UL1TR003015 and KL2TR003016. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.Funding StatementNo funding was needed or received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Marshall University Institutional Review Boards and Ethics Review Board approved the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author, EE, upon reasonable request.CVDCardiovascular diseases TGD TransgenderGAHTGender-affirming hormone therapy BMI Body mass indexCADCoronary artery disease LDL Low-density lipoprotein HbA1C Glycated hemoglobin DM Diabetes MellitusFTMFemale to male MTF Male to femaleHIVHuman Immunodeficiency Virus